To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
ABN Amro sells Accantia to Duke Street
ABN Amro Capital has sold healthcare products portfolio company Accantia to Duke Street Capital in a secondary buyout worth £225m.
